Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
red blood cells (3 trials)
COVID-19 convalescent plasma (1 trial)
plasminogen (Ryplazim) (1 trial)
albumin (Human) (Plasbumin) (1 trial)
sodium chloride (2 trials)
furosemide (lasix) (1 trial)
autologous platelets (1 trial)
blood plasma (1 trial)
Conjunctivitis (Phase 3)
Sepsis (Phase 2)
Shock (Phase 2)
Shock, Septic (Phase 2)
Skin Diseases, Genetic (Phase 3)
Toxemia (Phase 2)
Transfusion Reaction (Phase 1)
Trials (9 total)
Trial APIs (8 total)